Stanozolol USP29, Ph.Eur.5.5, Micronized grade
Molecular Formula: C22H36N2O
Molecular Weight: 344.53 gm/mol
Active life: 8 hours
Detection Time: 3 weeks
Anabolic/Androgenic Ratio (Range): 320:30
Stanozolol®, brand of Stanozolol tablets, is an anabolic steroid, a synthetic derivative of testosterone. Each tablet contains 5 mg and 10 mg of Stanozolol USP29, Ph.Eur.5.5, micronized grade. It is designated chemically as 17-methyl-2’H -5α-androst-2eno[3,2-c]pyrazol-17β-ol.
Each tablet also contains lactose monohydrate, sodium starch glycolate, polyvidone 25,000, microcrystalline cellulose and magnesium stearate as excipients. The 5 mg tablet also contains yellow ferric oxide (E172) and indigo carmine aluminium lake (E132) as colouring agent and the 10 mg tablet also contains yellow ferric oxide (E172)
Stanozolol® is an oral androgen derived from dihydrotestosterone. Stanozolol® acts on androgen receptors to promote anabolism through increased nitrogen retention and protein synthesis in muscle tissue. Stanozolol® is a strong anabolic substance with androgenic action. Stanozolol does not convert to estrogen and therefore does not produce typical estrogen mediated side effects such as water retention. Stanozolol has a large oral bioavailability, due to a C17 a-alkylation which allows the hormone to survive first pass liver metabolism. Stanozolol reduces SHBG increasing free testosterone levels.